Skip to main content
Clinical Trials/NCT07316946
NCT07316946
Not yet recruiting
Not Applicable

Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial

Sandra Jiménez-del-Barrio1 site in 1 country62 target enrollmentStarted: February 13, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Sandra Jiménez-del-Barrio
Enrollment
62
Locations
1
Primary Endpoint
Actual Pain Intensity

Overview

Brief Summary

Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial

Detailed Description

Randomized clinical trial 2 arms

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Double (Participant, Outcomes Assessor)

Masking Description

participants and outcome assessors will be blinded

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • age over 18 years
  • compete in a sport that involves overhead movement patterns
  • train at least 2 hours per week
  • shoulder pain lasting more than six weeks
  • shoulder pain related to sports activity
  • understand Spanish fluently enough to complete the questionnaire assessment.

Exclusion Criteria

  • presence of red flags that could suggest fractures, dislocations, or complete tendon ruptures, among others
  • neurological pathologies
  • other severe pathologies such as inflammatory arthritis, frozen shoulder
  • having received corticosteroid injections or physiotherapy treatment in the last six months
  • presence of previous surgeries
  • pregnancy
  • cognitive deficits that could limit the comprehension of the questionnaires or the physical evaluation
  • skin problems that would be a contraindication for any type of bandage.

Outcomes

Primary Outcomes

Actual Pain Intensity

Time Frame: Baseline, after 30 minutes of the intervention and 72 hours after intervencion

Pain intensity will be assessed using a 10-cm visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to rate the intensity of pain experienced at the time of measurement

Pain Intensity during the arm elevation

Time Frame: Baseline, 30 minutes after intervention and 72 hours after intervention

Pain intensity will be assessed using a 10-cm visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to rate the intensity of pain experienced during arm elevation.

Secondary Outcomes

  • Static Scapular Position(Baseline, 30 minutes after intervention and 72 hours after intervention)
  • Range of Motion(Baseline, 30 minutes after intervention and 72 hours after intervention)
  • Functional Capacity(Baseline, 30 minutes after intervention and 72 hours after intervention)

Investigators

Sponsor
Sandra Jiménez-del-Barrio
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Sandra Jiménez-del-Barrio

PhD Physiotherapist

University of Valladolid

Study Sites (1)

Loading locations...

Similar Trials